Ayala is an Arc Ventures portfolio company since 2018 . The official press release can be found on the company's website. REHOVOT, Israel & WILMINGTON, Del., May 12, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and…
Ayala Pharmaceuticals Announces Closing of Initial Public Offering
